Canada markets closed

Swedish Orphan Biovitrum AB (B6E.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
19.75-0.33 (-1.67%)
At close: 03:43PM CET
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
17,696,000
15,529,000
15,261,000
14,248,000
9,138,892
Cost of Revenue
4,484,000
3,484,000
3,225,000
3,335,000
2,415,426
Gross Profit
13,212,000
12,045,000
12,036,000
10,913,000
6,723,466
Operating Expenses
Research Development
2,265,000
1,994,000
1,594,000
1,495,000
1,090,416
Selling General and Administrative
7,550,000
6,294,000
5,981,000
4,935,000
2,510,740
Total Operating Expenses
9,735,000
8,258,000
7,573,000
6,414,000
3,599,025
Operating Income or Loss
3,477,000
3,787,000
4,463,000
4,499,000
3,124,441
Interest Expense
-
419,000
454,000
241,000
56,463
Income Before Tax
2,978,000
3,295,000
4,217,000
4,247,000
3,081,735
Income Tax Expense
485,000
616,000
972,000
942,000
663,940
Income from Continuing Operations
2,493,000
2,679,000
3,245,000
3,305,000
2,417,795
Net Income
2,493,000
2,679,000
3,245,000
3,304,000
2,417,795
Net Income available to common shareholders
2,493,000
2,679,000
3,245,000
3,304,000
2,417,795
Basic EPS
-
9.08
11.01
11.29
8.97
Diluted EPS
-
9.03
10.90
11.22
8.93
Basic Average Shares
-
295,051
294,658
292,649
269,524
Diluted Average Shares
-
296,799
297,640
294,528
270,604
EBITDA
-
5,720,000
6,694,000
6,077,000
3,622,773